RX-1 Rhythm Express Remote Cardiac Monitoring System vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RX-1 Rhythm Express Remote Cardiac Monitoring System

by VivaQuant

AVIEW

by Coreline Soft Co.

AI Verdict

Tool A, RX-1 Rhythm Express, is a wearable ECG monitoring system focused on real-time arrhythmia detection and remote cardiac monitoring for patients. Tool B, AVIEW, is an AI platform that analyzes CT scans for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. While both tools operate in the 'Cardiology AI' category, their core functionalities and data sources are distinct, making them adjacent rather than direct competitors.

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose the RX-1 Rhythm Express Remote Cardiac Monitoring System if you need continuous, long-term ECG monitoring for patients with suspected or diagnosed non-life-threatening arrhythmias, such as atrial fibrillation, or for evaluating symptoms like dizziness or palpitations. Its wearable, water-resistant design and extended battery life make it ideal for outpatient use, allowing patients to maintain their daily activities while providing physicians with near real-time data for enhanced diagnostics and monitoring of antiarrhythmic therapy.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Choose AVIEW if…

Choose AVIEW if your practice focuses on the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification through CT scans. This AI platform is particularly well-suited for streamlining radiology workflows, offering automated analysis of lung nodules, emphysema quantification, and coronary artery calcium scoring, which can significantly enhance diagnostic precision and reduce interpretation time.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RX-1 Rhythm Express Remote Cardiac Monitoring System	AVIEW
Pricing	Available via subscription, fee-for-service, or split-bill models.	Subscription; one-off payment
Deployment	Wearable device for patients, cloud-based platform for data management and review.	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A, the RX-1 Rhythm Express, emphasizes patient comfort and ease of use with its compact, water-resistant, patch-style design and simple one-button operation. Patients can wear it continuously, even in the shower, and quick-start guides and instructional videos are available. Tool B, AVIEW, is a complex diagnostic platform for radiologists, and while it aims to streamline workflows, its inherent nature involves intricate imaging analysis, suggesting a steeper learning curve for its users.

Clinical Value

AVIEW

AVIEW demonstrates strong clinical value through numerous published studies validating its accuracy in lung cancer screening, coronary artery calcium scoring, and emphysema analysis. It has been adopted as a standard AI platform in European lung cancer screening programs and is integrated into major U.S. medical centers. The RX-1 Rhythm Express is FDA-cleared and uses proprietary technology for noise suppression and arrhythmia detection, but the breadth of publicly available clinical validation studies for its diagnostic accuracy is not as extensively highlighted as for AVIEW.

Pricing & Value

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A offers transparent and flexible pricing models, including subscription, fee-for-service, and split-bill options, allowing clinics to choose the model that best fits their financial structure and bill globally. This predictability in costs and control over billing provides clear value. Tool B also offers subscription and one-off payment models based on installations and users, but specific details on pricing transparency or how these models translate to cost-effectiveness for clinics are less elaborated.

Enterprise Readiness

AVIEW

AVIEW demonstrates strong enterprise readiness with its flexible deployment options (cloud, hybrid, local hardware, virtualized) and integration capabilities with PACS/RIS/CIS. Its adoption in national-scale lung cancer screening programs in Europe and integration into major U.S. medical centers further highlight its proven scalability and robust infrastructure for large healthcare systems. The RX-1 Rhythm Express is a wearable device with a cloud-based platform, and while it supports numerous clinics, its enterprise readiness is more focused on remote monitoring services rather than broad system integration across diverse hospital IT environments.

Innovation

Tie

Both tools showcase significant innovation within their respective domains. RX-1 Rhythm Express features proprietary Multi-Domain Signal Processing (MDSPu2122) technology for superior noise suppression and AI-enabled arrhythmia detection in a compact, water-resistant wearable. AVIEW utilizes AI for comprehensive analysis of CT scans for multiple conditions (lung cancer, COPD, CAC), offering advanced features like automated segmentation, 3D visualizations, and workflow automation. Both represent cutting-edge applications of AI in healthcare.

Support & Docs

RX-1 Rhythm Express Remote Cardiac Monitoring System

The RX-1 Rhythm Express provides comprehensive patient resources, including quick start instructions, detailed patient use guides in multiple languages, and instructional videos, alongside 24/7/365 support via phone and email. This indicates a strong focus on user support and clear documentation for both patients and clinicians. While AVIEW aims to streamline radiology workflows, specific details about the breadth and accessibility of its support and documentation for end-users are not as explicitly detailed in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RX-1 Rhythm Express Remote Cardiac Monitoring System	AVIEW
Name	RX-1 Rhythm Express Remote Cardiac Monitoring System	AVIEW
Company	VivaQuant	Coreline Soft Co.
Description	An FDA-cleared, patch-style wearable device offering continuous ECG monitoring in MCT, Event, and Holter modes. It utilizes proprietary MDSPu2122 technology for superior noise suppression and accurate arrhythmia detection, providing near real-time data transmission to a cloud platform for physician review.	AI platform offering comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
Primary Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Oncology AI, Radiology & Imaging AI
Key Features (Cardiology)	Continuous 2-channel ECG monitoring, Mobile Cardiac Telemetry (MCT), Event Recorder (ER), and Wireless Holter (WH) modes, Automated arrhythmia detection and patient-triggered event recording	Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification), Automated segmentation of coronary arteries
Key Features (Other)	Proprietary Multi-Domain Signal Processing (MDSPu2122) technology for noise suppression, AI-enabled advanced signal processing for arrhythmia detection, Extended battery life (up to 5 days on a single charge), Water-resistant (IP64) and compact design, Built-in cellular connectivity for near real-time data transmission	AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), Emphysema quantification and low attenuation area (LAA) analysis, Automated segmentation of lung lobes, airways, vessels, 3D visualizations and comprehensive PDF reports, Workflow automation and integration with PACS/RIS/CIS, Follow-up registration and nodule matching for serial CT scans, Interstitial Lung Disease (ILD) pattern analysis (AVIEW Lung Texture)

Videos

Demos, reviews, and walkthroughs featuring RX-1 Rhythm Express Remote Cardiac Monitoring System and AVIEW.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and radiology workflows?

The RX-1 Rhythm Express system partners with a third-party EHR integrator that has completed over 9,000 integrations across more than 90 EHRs, aiming to ensure smooth data flow and reduce administrative burden. AVIEW is designed for workflow automation and integration with PACS/RIS/CIS, and its latest version, AVIEW 2.0, is noted for transforming radiology workflows by consolidating multi-disease CT assessment into a streamlined, automated process.

What is the accuracy and sensitivity of each tool in detecting relevant clinical conditions?

The RX-1 Rhythm Express utilizes proprietary MDSPu2122 technology and AI-enabled signal processing for superior noise suppression and arrhythmia detection, with diagnostic accuracy meeting or exceeding traditional Holter monitors and enhanced P-wave visibility. AVIEW demonstrates high accuracy in detecting lung nodules and quantifying coronary artery calcium (CAC). For lung nodules, studies show per-nodule sensitivity ranging from 32.6% to 72.1% depending on nodule type and radiologist experience, and a per-patient sensitivity of 100% with a specificity of 70.8% in one study. For CAC scoring, AVIEW has shown substantial agreement with radiologists' interpretations (kappa=0.793 & 0.671) and high sensitivity (92.9%) and specificity (96.0%).

What is the typical learning curve for physicians and staff when adopting these tools?

The RX-1 mini is designed for effortless setup for both healthcare providers and patients, with a five-step process for device activation. Rhythm Express also provides comprehensive training and ongoing support for staff. While specific learning curve data for AVIEW isn't provided, AI tools in radiology are generally seen as a way to alleviate workload, and studies on learning curves for radiograph interpretation suggest proficiency improvements with practice. AVIEW's user-friendly viewer also visualizes CT findings in 3D, which can be more informative.

What kind of customer support and training are available for these tools?

VivaQuant offers 24/7/365 phone and email support for both patients and providers for the RX-1 Rhythm Express, including troubleshooting and training on software, website, and device usage. Rhythm Express also provides comprehensive patient education materials. For AVIEW, the information provided does not detail specific customer support or training programs, but its widespread use in numerous countries and integration into major medical centers suggests established support mechanisms.

Beyond standard compliance, what are the security features and audit-trail capabilities of each tool?

The RX-1 Rhythm Express uses NSA-level encryption for data transmission and employs a cybersecurity service (Arctic Wolf or Red Canary) for 24/7/365 monitoring of its cloud-based systems and event response. It also conducts regular security audits, vulnerability scanning, and staff training. While specific audit-trail features for RX-1 are not detailed, audit logging is a core HIPAA requirement for safeguarding ePHI. AVIEW's audit-trail features are not explicitly described in the provided information, but generally, audit trail features enable the review of changes to objects and system settings, with records typically including date/time, entity name, entity type, user, and actions.

How do these tools support multi-site or large-scale rollouts?

The RX-1 Rhythm Express has been adopted by over 600 clinics and has monitored more than 200,000 patients nationwide, indicating its scalability for multi-site rollouts. AVIEW has processed over 2.5 million cases across 19 countries and has been selected as the AI platform for government-led lung cancer screening programs in Germany, France, and Italy, demonstrating its capability for large-scale deployments.

What clinical context or specific patient populations are best suited for each tool?

The RX-1 Rhythm Express is intended for adult patients with or at risk of cardiac disease, including those with non-life-threatening arrhythmias (e.g., atrial fibrillation, atrial flutter), bradyarrhythmias, and arrhythmias associated with co-morbid conditions like hypothyroidism or chronic lung disease. It's also suitable for evaluating syncope of unknown etiology and monitoring antiarrhythmic therapy. AVIEW is designed for early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans. It supports lung nodule detection and characterization, emphysema quantification, and coronary artery calcium scoring, making it valuable for radiologists, pulmonologists, and cardiologists involved in lung cancer screening and opportunistic screening for cardiac risk.